medigraphic.com
SPANISH

Salud Pública de México

Instituto Nacional de Salud Pública
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 3

<< Back Next >>

salud publica mex 2020; 62 (3)

Prevention and control of SARS-CoV-2 (Covid-19) coronavirus infection in hemodialysis units

Vega-Vega O, Arvizu-Hernández M, Domínguez-Cherit JG, Sierra-Madero J, Correa-Rotter R
Full text How to cite this article

Language: Spanish
References: 8
Page: 341-347
PDF size: 316.79 Kb.


Key words:

hemodialysis, primary prevention, pandemic, coronavirus infection, recommendations.

ABSTRACT

The SARS-CoV-2 pandemic is of hich risk for patients on chronic hemodialysis due to their immunosuppressed state, advanced age, and the coexistence of significant comorbidities, in particular cardiovascular disease, diabetes mellitus, and others. Additionally, they constitute a closed conglomerate since they come to treatment regularly, spending hours in the treatment places, exposed to a possible acquisition of the infection. Finally, going to their treatment regularly prevents them from remaining in home isolation and with potential exposure. These recommendations summarize the interventions proposed by three international organizations and add some suggested by national experts, with the aim to early identify the patients and health personnel at risk and reducing the risk of infection.


REFERENCES

  1. Adhanom T. WHO Director-General´s opening remarks at the Mission briefing on COVID-19-12 March 2020. Ginebra, Suiza: World Health Organization [citado marzo 20, 2020]. Disponible en: https://www.who.int/dg/ speeches/detail/who-director-general-s-opening-remarks-at-the-missionbriefing- on-covid-19---12-march-2020

  2. Rodríguez-Morales A, Bonila-Aldana K, Balbin-Ramon GJ, Rabaan AA, Sah R, Paniz-Mondolfi A, et al. Hisotory is repeating itself: probable zoonotic spillover as the cause of the 2019 novel coronavirus epidemic. Le Infezioni in Medicina. 2020;1:3-5. https://doi.org/10.13140/ RG.2.2.36592.40962

  3. Ma Y, Diao B, Ly X, Zhu J, Liang W, Liu L, et al. 2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China [e-pub ahead of print]. medRxiv. 2020. https://doi. org/10.1101/2020.02.24.20027201

  4. Centers of Disease Control and Prevention. Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities. Atlanta, USA: CDC [citado marzo 19, 2020]. Disponible en: https:// www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/dialysis.html

  5. Sociedad Española de Nefrología. Protocolo de actuación ante la pandemia de enfermedad por coronavirus en los pacientes de diálisis y trasplantados renales. Cantabria, España: Sociedad Española de Nefrología [citado marzo 19, 2020]. Disponible en: https://senefro.org/modules.php?n ame=webstructure&idwebstructure=157

  6. Arenas MD, Villar J, González C, Cao H, Collado S, Crespo M, et al. Manejo de la epidemia por coronavirus SARS-CoV-2 (Covid 19) en unidades de hemodiálisis [e-pub ahead of print]. Nefrología [citado marzo 19, 2020]. Disponible en: https://www.senefro.org/modules. php?name=noticias&d_op=view&idnew=1170

  7. Sociedad Latinoamericana de Nefrología e Hipertensión. Recomendaciones para el manejo de pacientes portadores de enfermedad renal frente a la epidemia de coronavirus (COVID-19). Panamá: SLANH [citado marzo 19, 2020]. Disponible en: https://slanh.net/recomendaciones-parael- manejo-de-pacientes-portadores-de-enfermedad-renal-frente-a-laepidemia- de-coronavirus-covid-19/

  8. Nucamendi-Cervantes GC, Dirección de Vigilancia Epidemiológica de Enfermedades No Transmisibles. Oficio No. DGE-DG-DVEENT 02595 2020. México: Gobierno de México, Secretaría de Salud [Difundido 2020 marzo 24].




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

salud publica mex. 2020;62